Cardiac Risk in Liver Transplantation: Getting to the “Heart” of the Matter
Recorded On: 09/10/2018
The overall objective of this activity is to address the epidemiology, risk factors and key challenges in the evaluation and management of cardiovascular disease in liver transplant candidates. In particular, we will discuss the evolving role of cirrhotic cardiomyopathy as a marker of ongoing cardiac injury.
Lisa VanWagner (Moderator)
Dr. Lisa VanWagner is an Assistant Professor of Medicine and Preventive Medicine in the Division Gastroenterology & Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. She is board certified in Transplant Hepatology. Her laboratory utilizes human population-based approaches, large electronic health record data analysis and health services research methods to define and characterize cardiovascular disease risk prediction, prevention and treatment approaches in patients with chronic liver disease. Her research group developed the first simple scoring model (CAR-OLT score) — accessible via web or smartphone apps — which enables healthcare providers, caregivers and patients to estimate 1-year risk for cardiovascular complications after liver transplantation.
Sam Lee (Moderator)
Dr. Mario Altieri is currently the medical director of the liver transplant program at the University Hospital Center in Caen, France since November, 2012. He did his Fellowship in intensive care medicine and Fellowship in multiple organ transplantation (liver, kidney and pancreas) at Strasbourg University France Hospital, University Center Hospital HUC. He was the Chief of residency in Internal Medicine Cordoba, Argentina (Specialist certified NUCA) and was professor in intensive care medicine catholic University of Cordoba from 2000 to 2002.
Dr. Manhal Izzy is a transplant hepatologist and an assistant professor at Vanderbilt University School of Medicine. He is a member of the educational committee of the International Liver Transplantation Society (ILTS). His research focuses on cardiovascular outcomes in patients with liver disease.